Ajanta Pharma Usa
Pharmaceuticals, 440 Hwy 22 East, Bridgewater, New Jersey, 08807, United States, 11-50 Employees
Phone Number: 19*********
Who is AJANTA PHARMA USA
Ajanta Pharma USA Inc., based in Bridgewater, New Jersey, is a wholly owned subsidiary of Ajanta Pharma Ltd. Ajanta Pharma is committed to delivering quality generic drugs to patients, th...
Read More
-
Headquarters: 440 Hwy 22 East, Bridgewater, New Jersey, 08807, United States
-
Date Founded: 1973
-
Employees: 11-50
-
Revenue: $25 Million to $50 Million
-
Active Tech Stack: See technologies
Industry: Pharmaceuticals
SIC Code: 2834
Does something look wrong? Fix it. | View contact records from AJANTA PHARMA USA
Ajanta Pharma USA Org Chart and Mapping
Email
Phone
Similar Companies to Ajanta Pharma USA
Amneal Pharmaceuticals
-
5001-10000
-
$ 1 Billion and Over
Glenmark Pharmaceuticals
-
10001+
-
$ 500 Million to 1 Billion
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Ajanta Pharma USA
Answer: Ajanta Pharma USA's headquarters are located at 440 Hwy 22 East, Bridgewater, New Jersey, 08807, United States
Answer: Ajanta Pharma USA's phone number is 19*********
Answer: Ajanta Pharma USA's official website is https://ajantapharmausa.com
Answer: Ajanta Pharma USA's revenue is $25 Million to $50 Million
Answer: Ajanta Pharma USA's SIC: 2834
Answer: Ajanta Pharma USA has 11-50 employees
Answer: Ajanta Pharma USA is in Pharmaceuticals
Answer: Ajanta Pharma USA top competitors include: Amneal Pharmaceuticals , Glenmark Pharmaceuticals
Answer: Ajanta Pharma USA contact info: Phone number: 19********* Website: https://ajantapharmausa.com
Answer: Ajanta Pharma USA Inc., based in Bridgewater, New Jersey, is a wholly owned subsidiary of Ajanta Pharma Ltd. Ajanta Pharma is committed to delivering quality generic drugs to patients, through collaboration with its industry partners. Ajanta Pharma is dedicated to superior service, supply chain reliability and flexibility to meet the unique needs to its customers. Since making the strategic decision to enter the US market, our Research and Development (R&D) team began developing a product portfolio of Abbreviated New Drug Application (ANDA) filings with a mix of Immediate-Release, Extended-Release, Delayed-Release, Orally Disintegrating Tablets and Powders.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month